News | Computed Tomography (CT) | August 08, 2016

Findings of ultra-low cost study reveal more differences in CT lung cancer screening protocols than expected, highlighting need for better communication, education and resources

CT lung cancer screening, computed tomography, crowd-sourced study, image quality, Prevent Cancer Foundation workshop

August 8, 2016 — An overview of the initial findings and results from the CT Lung Screening Protocol Challenge was announced at the Prevent Cancer Foundation Quantitative Imaging Workshop on June 13, 2016.

This first-of-its-kind study allowed researchers to evaluate the protocols and image quality performance of currently-deployed computed tomography (CT) scanners for low-dose CT lung cancer screening. The researchers also obtained initial data on the applicability of these scanners and protocols for chronic obstructive pulmonary disease (COPD). The use of 3M Scotch Magic tape as an image quality reference object provided an ultra-low cost and novel method of evaluating fundamental CT image quality performance across a scanner’s field of view. 3M Scotch tape is manufactured so that this product’s dimensions are extremely consistent.

Over a two-month data collection period, the information received from CT lung cancer screening image data was automatically analyzed. Data were received from 26 healthcare institutions, 53 CT scanners and approximately 128 individual CT scans. Preliminary analysis of the study data revealed larger differences in CT scanning protocols than expected, despite low-dose lung cancer screening recommendations and guidelines from major societies. These data highlighted the need for more communication, education and resources for establishing and verifying CT imaging protocols.

The study data also revealed a critical need to continue collecting large databases of image quality data and also revealed many opportunities to improve CT scanners and imaging methods to better support detection and quantitative measurement of early lung disease.

The Challenge data review committee is now preparing a manuscript of the preliminary Challenge findings, which will be submitted for review in August.

For more information: www.preventcancer.org


Related Content

News | Magnetic Resonance Imaging (MRI)

April 17, 2024 — Hyperfine, Inc., a groundbreaking health technology company that has redefined brain imaging with the ...

Time April 17, 2024
arrow
News | Clinical Trials

April 16, 2024 — QT Imaging Holdings, Inc., a medical device company engaged in research, development, and ...

Time April 16, 2024
arrow
News | Mammography

April 12, 2024 — Bayer and Hologic, Inc. announced a first-of-its-kind collaboration to deliver a coordinated solution ...

Time April 12, 2024
arrow
News | Mammography

April 12, 2024 — GE HealthCare, a leader in breast health technology and diagnostics, will feature its latest breast ...

Time April 12, 2024
arrow
News | Population Health

April 4, 2024 — A new study found increased coronary vessel wall thickness that was significantly associated with ...

Time April 04, 2024
arrow
News | Radiation Oncology

April 2, 2024 — In a 10-center study, microwave ablation offered progression free survival rates and fewer complications ...

Time April 02, 2024
arrow
News | Radiation Therapy

March 28, 2024 — RefleXion Medical, Inc., a therapeutic oncology company, and Limbus AI, Inc., a provider of software ...

Time March 28, 2024
arrow
News | ACR

March 21, 2024 — The Advanced Research Projects Agency for Health (ARPA-H) has appointed American College of Radiology ...

Time March 21, 2024
arrow
News | Coronavirus (COVID-19)

March 21, 2024 — Artificial intelligence can spot COVID-19 in lung ultrasound images much like facial recognition ...

Time March 21, 2024
arrow
News | Breast Imaging

March 20, 2024 — IceCure Medical Ltd., developer of the ProSense System, a minimally-invasive cryoablation technology ...

Time March 20, 2024
arrow
Subscribe Now